All News
All news
-
News EMBO CAPS® by Suheung LP+ Liquid Capsule
Supplied globally under the Embocaps® by Suheung brand, the Embocaps® LP+ is a hard capsule specifically designed to hold liquids and fine powders. The Embocaps® LP+ is available in multiple gelatin, vegetarian and relayed release formulations. -
News EMBO CAPS ® by Suheung opens new capsule factory
Suheung Co., Ltd. today announces the opening of their new EMBO CAPS® VG-ALPHA capsule facility located in the Long Thanh Industrial Zone (Dong Nai Province), Vietnam. Exclusively a vegetarian capsule facility, the new factory will supply capsules... -
News EMBO CAPS® by Suheung receives China DMF Number for Gelatin
EmboCaps® by Suheung announces today that the China DMF filing for Empty Hard Gelatin Capsule(F20190000400) successfully completed on December 30, 2019 -
News EMBO CAPS® by Suheung receives China DMF Number for HPMC
Suheung Co., Ltd. announces today that the China DMF filing for it’s EMBOCAPS ® Empty Hard HPMC Capsules has been successfully submitted and received its DMF filing acceptance notice / Pre-assigned DMF Number F20190000399. -
News Getinge launches the DPTE® Transfer Trolley - safe, smart and simple
Getinge launches the DPTE® Transfer Trolley – a smart, mobile transfer platform for use with all standard DPTE® Beta solutions for moving materials into and out of a confined zone without breaking containment or sterility. Its ergonomic, ... -
News Our CEO shares his thoughts on leading Nemera during the coronavirus pandemic in Pharma Post’s Special issue
None of us imagined we would be living through times like these. Every phase of this pandemic is unprecedented and we are inundated with guidelines to keep ourselves and our loved ones safe. We were not completely prepared for such a cris... -
News Nemera and Noble announce collaboration to support patients who self-administer medication
Nemera, world leader in design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries, today announced a collaboration with Noble, the global leader in medical device training solution... -
News Nemera takes dermal treatments to millions of patients
Bioscience Today’s latest issue features Nemera’s article on how we strike the perfect balance of ensuring safety of our dermal drug delivery devices whilst fulfilling regulatory requirements and patient needs. -
News Nemera’s Insight Innovation Center celebrates a year of successful integration of expanded services
In August 2019, global drug delivery leader Nemera acquired top innovation services firm Insight Product Development. Today, Nemera’s Insight Innovation Center offers end-to-end development services from early to late-stage with design research, ... -
News “Smart, interactive and automated devices ergo ‘electronic’ are the future of drug delivery devices”
Drug Development Delivery’s latest issue features Nemera’s article titled: magazine includes an article from Nemera: ‘Mapping the regulatory strategy to better navigate electronic drug delivery device development for patient safety & security’ -
News Nemera awarded silver medal in the EcoVadis sustainability assessment
At Nemera we are committed to conducting business in an ethical and socially responsible way. Our people are passionate about making products that improve patient’s lives whilst being conscious about the impact we make on the world around us. We ... -
News Serialization and aggregation in the pharmaceutical industry
The serialization system allows the verification of a drug's compliance from the distribution to the delivery then to the patient. This article explains the serialization and aggregation implemented at Skyepharma. -
News Skyepharma Analytical Services : Specialized teams
Skyepharma is a full CDMO. We have an analytical service that covers all aspects from development to manufacturing. Packaging, raw materials and finished products are all controlled by this service. -
News Skyepharma overcomes Russian serialisation complexities
Skyepharma has extended its serialisation and aggregation service to ‘hard to reach’ countries like Russia and Brazil. We are now able to offer serialized and aggregated supplies to Russia. -
News Supply Chain Reliability at Skyepharma, David Lescuyer's Interview
This article describes the robustness of Skyepharma's supply chain. The delivery of our products has not been impacted during this COVID-19 pandemic. Discover how! -
News Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. -
News The pharmaceutical sector in the Gulf Cooperation Council and the impact of COVID-19
Countries in the GCC have been concentrating their efforts to develop and grow their healthcare and pharmaceutical sectors as an integral part of a ten-year vision to diversify the region’s economy and reduce its dependency on crude oil. While th... -
News Gilead Sciences agrees to buy Immunomedics in $21 billion deal
Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer. -
News Stevanato Group to open US Technology Excellence Center in Boston
Due to begin operations in late September, the US TEC will bring value-added laboratory services to the heart of the biotech community. -
News Dexamethasone sodium phosphate in syrup
Discover our new Dexamethasone sodium phosphate in syrup 2mg/5ml -
News MACROGOL 3350 in stick pack and jar
Treatment of chronic, accasional or medication induced constipation.Pack: stick pack & jar
Fill: 5g - 10g- 200g -
News HYALURONIC ACID in Mesotherapy
Discover Hyaluronic Acid in Pre-Filled syringes & glass vials -
News Ensiemo, the new complete child-resistant packaging solution for cbd oils
SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market. Combining the company’s extensive pharmaceutical packaging expertise with the need for compliant, safe packaging for CBD oils, ... -
News Maverick: an emergency auto-injector designed for total patient safety
The Maverick emergency auto-injector merges Duoject Medical System’s design and development expertise with Stevanato Group’s contract manufacturing capabilities. Six Human Factor studies conducted over 150 patients show how the current conf... -
News Medicine to beat the papiloma virus
Procare Health makes its way into the health sector with a gel to treat and prevent a disease that affects mainly women -
News Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19. -
News Univercells Technologies introduces new upstream platform for virus manufacturing
The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing. -
News Mylan and development partner win significant EPO ruling related to Copaxone
Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe. -
News Fertin Pharma Issued U.S. Patent for Oral Delivery Tablet Formed by the Compression of Unique Sugar Alcohol Combinations
U.S. Patent No. 10,632,076 B2 further strengthens Fertin Pharma’s intellectual property (IP) portfolio -
News Peter Halling to become new CEO of Fertin Pharma following resignation of Søren Birn
Peter Halling has been appointed CEO of Fertin Pharma as of August 2020. -
News Evotec and Bioaster partner to build technology and innovation hub in Lyon
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies. -
News Biogen invests $250 million to eliminate its use of fossil fuels
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040. -
News Annual Report preview for the CPHI Festival of Pharma
This preview from BioPlan Associates for the CPHI Festival of Pharma from 5-16 October, includes a summary of global trends and growth opportunities in biopharmaceutical product development and manufacturing and how the growth of domestic Mab pipelines... -
News Bushu Pharmaceuticals Quality Manufacturing of All Things Biotech
When western companies have established themselves in their regions, the Asian markets hold opportunities for their business expansion. In there, Japan is a one of prime targets for these expanding companies. However, launching into an unfamiliar marke... -
News Sai Life Sciences joins the ACS Green Chemistry Institute Pharmaceutical Roundtable
We have been committed to increasing the adoption of Green Chemistry principles in our process development. Joining the ACS-GCIPR will allow us to interact with large pharma and other CDMOs to further share and develop best practices in Green c... -
News Sai Life Sciences receives the 21st National Award for Excellence in Energy Management 2020
Following a string of wins over the past year, our Bidar manufacturing facility achieved another success to its credit - this time for excellence in energy management
-
News Stevanato Group Launches Robotic Human-like Inspection Unit with AI-based Machine Learning Capabilities
The Vision Robot Unit will provide biopharma companies with a fully automatized, highly accurate and flexible inspection system equipped with artificial intelligence for a variety of drug products, for increased operational efficiency. -
News Farmabios expands its portfolio with Cannabidiol API
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios is now positioned to fulfill a secure and ... -
News Pharmapack 2021 opens entries for Patient-Centric Design Awards
The global pandemic continues to impact lots of industries and slow down business, but the pharma and packaging industries are striving to tackle new challenges to bring more faster and safer solutions to deliver medication to patients. The Pharmapack ... -
News The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery
Pharmapack Europe, the leading conference & exhibition in pharma packaging & drug delivery business traded the successful 2020 edition at the beginning of February. The innovation gallery, as the key feature of this event, has gathered the most recent ... -
News What do Pharmapack Awards winners think about patient-centricity?
Pharmapack Awards winners and industry leaders will meet up in a live webinar at CPHI Festival of Pharma to discuss the evolution of next-generation products in pharma packaging, administration & drug delivery devices. -
News Sympfiny® acceptability study among young children with positive results
Scientists at the University of Birmingham, UK have evaluated Sympfiny® as device for orally dispensing multiparticulate drugs to children aged 4-12. -
News Sympfiny® showcase in OnDrugDelivery: The advantages of multiparticulate drug formulations in paediatric medicine
Multiparticulates, an emerging technology with many advantages over traditional dosage forms are particularly suited for use in paediatric medicine. The Sympfiny® system is specifically tailored to administering multiparticulate drug formulations,... -
News More than just wrapping a pill: improving patients’ lives through packaging
There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct... -
News Evive Biotech Meets Primary and Secondary Endpoints in Global Phase III Clinical Trial for Their Novel Chemotherapy-induced Neutropenia Treatment
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cance... -
News VAV Lipids gets written confirmation from CDSCO for Ratnagiri facility
VAV Lipids announced that it has received written confirmation for their lecithin and phospholipids manufacturing facility at Ratnagiri, India pursuant to a successful inspection carried out by Indian CDSCO. The written confirmation is required fo... -
News Mylan to acquire Aspen's thrombosis business in Europe
The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals. -
News Nippon Express to provide global pharmaceutical supply networks
The company is already constructing a digital platform for the pharmaceutical industry that will utilize IoT devices and blockchain technology to link temperature control and other logistics information end-to-end. -
News Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical ph... -
News Exelixis and Catalent collaborate to develop antibody-drug conjugates
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology. -
News Key trends boosting the post-pandemic CRO market
Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity. -
News INOVIO signs up Thermo Fisher to support COVID-19 vaccine production
The CDMO will support INOVIO's plans to have 100 million doses of COVID-19 vaccine candidate INO-4800 manufactured in 2021. -
News French cancer institute starts testing connected drug dispenser
THESS dispenser is equipped with an identity-vigilance system and warns patients when they need to take their treatment and verifies it has been delivered in accordance with the prescribed dose -
News COVID-19 ushers in age of digital, flexible EU pharmaceutical regulation
The pandemic that has swept over the world in 2020 has caused huge disruption to the European pharmaceutical industry's regulatory procedures and supply chain management. But the crisis has also provided a platform for a learning process for the sy... -
News KOLINPHARMA® expands its product portfolio with IVUXUR® TABLETS.
KOLINPHARMA® S.p.A. presents the new product IVUXUR® TABLETS, which is added to the other 9 patented or patent pending products, already present in the portfolio. -
News Bushu Pharmaceuticals Announces Major Expansion Program
Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced a major capital program costing $100 million to expand its footprint, capacity and portfolio of services. The program extends over the next ... -
News Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient Sciences, a lead... -
News JM to manufacture regulatory starting materials for Sarepta Therapeutics
Johnson Matthey (JM), a global leader in science that enables a cleaner and healthier world, has entered into a five-year supply agreement with Sarepta Therapeutics, Inc. to continue supplying regulatory starting materials to support Sarepta’s phosphor... -
News Gujarat, India's Pharma Hub
CPHI & P-MEC India and Global Business Reports are pleased to bring you the Gujarat Pharma 2020 report, sharing our view on the most attractive opportunities in the Indian pharma market. The report provides an outlook for the Gujarat region in India as... -
News DWK Life Sciences increases glass vial production capacity to meet demand
Best-in-class automation, robotics and state-of-the-art touchless production lines that provide the cleanliness required for parenteral packaging containers. -
News AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US
Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19. -
News Probiotical white paper_immune defenses high definition
An effective immune system is your best defense, and the right probiotics can help! The COVID-19 global crisis has led to a peak in demand for products able to stimulate immunity. Given the well-established importance of the microbiota in immune health... -
News Biological E and GVK BIO announce strategic R&D Partnership
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a... -
News GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as its New Chief Commercial Officer
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), is pleased to announce the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the appointment of Ramesh Subramanian, Ph.D., as its new ... -
News Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world’s largest vaccine ma... -
News Aragen Bioscience announces the appointment of Steven Lang, PHD, MBA as Vice President, Biologics
Aragen Bioscience is pleased to announce the appointment of Dr. Steven Lang as Vice President, Biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologics product development wi... -
News Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D i... -
News Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process
Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances -
News Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused o... -
News KORSCH introduces next-generation mid-range tablet press
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines. -
News Development of rapid novel SARS-CoV-2 diagnostics started
Enzyme specialists from EUCODIS Bioscience and diagnostics experts from Biosynth-Carbosynth have teamed up to develop a novel diagnostic tool for the fast and reliable detection of an acute SARS-CoV-2 infection. Based on viral enzymatic activities and ... -
News Managing Your Life Sciences Quality Management System Remotely
Telecommuting and online commerce has been with us for some time and works seamlessly in many industries, but the current state of events has forced companies to apply remote management to other areas that have historically been considered "hands-on" j... -
News SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate
SGS is pleased to announce the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its sp... -
News SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine
In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov... -
News Mylan and Biocon Biologics launch Lantus biosimilar in the US
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market. -
News Hovione Technology unveils collaboration for new asthma product in Turkey
Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler. -
News Pfizer sells biologics manufacturing facility in Adelaide
Bridgewest to develop the site into a full-service contract development and manufacturing organization. -
News CPHI Webinar Series - Key Trends in Contract Manufacturing
Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines. A recent C... -
News Grace Doubles LUDOX® Colloidal Silica Capacity with Major European Plant Opening
June 23rd, 2020: W. R. Grace & Co., a global leader in specialty silica, today announced the opening of its new 8,200 square-meter state-of-the-art, colloidal silica plant at its European flagship manufacturing and R&D center in Worms, Germa... -
News GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.
May 08, 2019, Hyderabad, India/California, US: GVK BIO is pleased to announce the appointment of Dr. Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc. -
News LifeArc And GVK BIO Celebrate A Decade Of Partnership, Transforming Research Into Life-Saving Medicines
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce -
News GVK BIO Announces USFDA Approval for its cGMP Analytical Services Laboratory
GVK BIO, a leading global Contract Research and Development Organisation, announced today that United States Food and Drug Administration (FDA) has approved its cGMP Analytical Service Laboratory located at IDA, Mallapur Campus, Hyderabad. The in... -
News GVK BIO Announces Appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors
GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors. -
News Diabetes, a world public health concern
Ingredia launched Pep2Dia®, specifically developed to help manage blood sugar level. This patented milk protein hydrolysate has an active dipeptide AP, which inhibits the alpha glucosidase. Preclinical and clinical studies have proven the efficacy ... -
News Connect-e-Cap®: A pillbox that pays attention
Röchling Medical's innovative intelligent packaging solution against non-adherence.
Connect-e-Cap® Reminds patients of the next required doseRecords fill level, opening time etc.Recognizes the container via pairing functionReads o... -
News WE HAVE MOVED
We are announcing a relocation... -
News Securing your end-to-end supply chain
Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis. -
News Covid-19: Looking for an effective antimicrobial agent?
Benzalkonium Chloride (BKC) is recommended by several national agencies as an effective agent to control infection by Covid-19. -
News We are now certified to ISO 45001
Whether you are an employee, a manager or a business owner, we share a common goal – we don’t want anyone to get hurt on the job. Therefore, employee health and safety conditions are incorporated in all our work tasks. -
News Oral Solid Dose Regulatory Hurdles and How to Approach Them
In your quest to meet the regulatory requirements for your oral solids project, you may encounter significant hurdles. Anticipating these early on and thoroughly planning your approach can help. Experts in the Pfizer CentreOne global network, Gillian M... -
News Supporting global industrial scale-up at a pandemic speed with Type 1 pharma glass containers and timely solutions
In a compressed timeframe, producing large quantities of pharmaceutical glass containers to deliver the coronavirus vaccine around the world is a critical factor for a successful global response. Type 1 glass is a proven and widely available solution f... -
News SGD Pharma will do everything to avoid vial shortages
Drugmakers are warning of a potential shortage of vials to bottle future COVID-19 vaccines, but their rush to secure supplies risks making matters worse, some major medical equipment manufacturers warn. -
News How is SGD Pharma Innovating through the Pandemic and Beyond to Define the Future of Healthcare?
SGD Pharma, one of That's Nice's Road to 2021 sponsors, discusses how the company is innovating to face the challenges of the COVID-19 pandemic and beyond to face the future of healthcare. -
News Pharma glass specialist’s positive response to Covid-19 crisis
As a key supplier to the global pharmaceutical industry, SGD Pharma is well versed in the process of contingency planning. This experience has greatly assisted the specialist glass packaging manufacturer in implementing its response to the Covid-... -
News SGD Pharma glass manufacturer is investing to prepare for the post-pandemic era
The pharmaceutical packaging specialist is preparing to relaunch an investment plan of 37 million euros in its two French factories -
News New syringe technology could make the 'uninjectable' injectable
Researchers have designed a simple, low-cost device for subcutaneous injection of viscous formulations. -
News Unigel: The Smart Softgel
Learn more on our unigel technology, platform for multi-purpose, multi-dose therapies in fixed dose combinations in softgels. Ready-to-market formulas available. -
News Driving advanced gummy solutions
Gummy supplements alone have gained the most market share in relation to others non-pill formats doubling in size over the last five years -
News During times of Self-Isolation and Social Distancing, Don’t Forget About Vitamin D
Vitamin D contributes to the maintenance of normal bones and muscle function and helps to reduce the risk of falling associated with postural instability and muscle weakness -
News Vegetarian substitues for Soft Gelatin Capsules
The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general insight of the current state of materials and technology of these gelatin ... -
News BMS adds lead TGF-beta asset to portfolio through acquisition
Forbius's lead investigational asset, AVID200 holds promise as an effective and well-tolerated therapeutic in fibrotic diseases and immuno-oncology. -
News Symbiosis confirms commitment to growth strategy with key appointment
The CMO's new Chief Operating Officer will continue the company's operational response to COVID-19. -
News Interview: Indian healthcare reform offers thriving pharmaceutical market opportunities
Global Pharma Insights speaks to Deepak Sapra, CEO of Active Pharmaceutical Ingredients and Services at Dr. Reddy's Laboratories, for his perspective on the current state of the Indian healthcare and pharmaceuticals sector -
News Pharmaceutical packagers scaling up to meet potential COVID-19 vaccine demand
Amid concerns that global immunization programs may suffer from a shortage of vials to hold doses of approved vaccines against COVID-19, pharmaceutical packagers are busy ensuring they have the required capacity to meet the huge demand. -
News Dr. Reddy’s partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19
Dr. Reddy's Laboratories Ltd. announces partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan® Tablets (generic name: favipiravir), a potentia... -
News Licensing Agreement with Gilead Sciences for Remdesivir
Dr. Reddy's announced that it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. (Gilead) that will grant Dr. Reddy’s the right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential trea... -
News Catalent expands manufacturing support for COVID-19 vaccine AZD1222
The company will prepare the Harmans facility to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing later this year. -
News CRO Europital opens new UK site in response to urgent demand
The company will target working with small and medium biotechs who require a science-driven, rather than a volume-driven partner. -
News Takeda to divest its Japan consumer healthcare business unit
The transaction will allow Takeda to focus on five key business areas. -
News US and UK Vaccine and Drug Investments and Purchases to date
This chart from investment advisory firm, Virtue Capital Partners Ltd, provides an up-to-date snapshot of how the US and the UK compare in terms of their respective investment in anti-COVID 19 vaccines and drugs, providing useful data such as number of... -
News Mineral Salts Low in Endotoxins for Pharmaceutical Applications
Endotoxins or pyrogens are lipopolysaccharides – outer membrane components of gram-negative bacteria. During decomposition or metabolism, these bacteria release lipopolysaccharides, which are toxic. Parenteral-induced quantities as low as 0.1ng/kg of b... -
News Pharma 2030 and Packaging
An exclusive interview with Mr. Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance -
News Russian Crypto Code
We have extended our #pharmaceutical #packaging competence to include cryptographic coding for the Russian market.
Our lines as well as printing and camera control systems are equipped with the necessary add-ons, connection to exter... -
News 3D printing: the key to unlock production of patient-specific meds?
3D printing technology has many potential advantages, such as reducing costs and speeding up manufacturing. But how suitable is it to enhancing pharmaceutical drug production? -
News Smart packaging solutions to COVID-19 counterfeiting
Developments in smart packaging can add value to the pharmaceutical supply chain and help to tackle the threat of counterfeit products as the race towards producing a COVID-19 vaccine heats up Dr Alex Cole, Senior Strategic Marketing Manager, CPI -
News ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19 Collaboration
ANA Therapeutics, a Silicon Valley-based biotech startup, and Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candida... -
News Cobra Biologics completes production of master cell banks for epilepsy gene therapy drug candidate
This milestone secures future production of CombiGene's CG01 drug candidate to treat drug-resistant focal epilepsy. -
News J&J agrees in principle to supply UK with its COVID-19 vaccine candidate
Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators. -
News Diabetes, a world public health concern
Today more than 350 million people live with high blood sugar glucose (1). In 5 to 10 years, if nothing is done, the people with prediabetes, who have a higher-than-normal glycaemia in the morning fasting, will become diabetic. Everywhere, diabetes is... -
News Organic Iron Salts as APIs from Dr. Paul Lohmann®
Dr. Paul Lohmann® has recently developed Iron(III) Polymaltose Complex and Iron(II) Bisglycinate as active pharmaceutical ingredients. These products are available including API documentation (DMF/ASMF) for the registration of a medicinal drug at the h...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance